{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:42:52Z","timestamp":1792784572417,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"TUBITAK","award":["113S036"],"award-info":[{"award-number":["113S036"]}]},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","award":["VS.054.13N.LC"],"award-info":[{"award-number":["VS.054.13N.LC"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.talanta.2016.09.053","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T05:17:24Z","timestamp":1475212644000},"page":"268-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["A sensitive capillary LC-UV method for the simultaneous analysis of olanzapine, chlorpromazine and their FMO-mediated N-oxidation products in brain microdialysates"],"prefix":"10.1016","volume":"162","author":[{"given":"Stijn","family":"Hendrickx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu Yeniceli","family":"U\u011fur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u015fil Tan","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"\u015eener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Van Schepdael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Broeckhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Cabooter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2016.09.053_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Perala","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.talanta.2016.09.053_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1359786810385490","article-title":"Suicide and schizophrenia: a systematic review of rates and risk factors","volume":"24","author":"Hor","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.talanta.2016.09.053_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jcla.20345","article-title":"Rapid liquid chromatography\/tandem mass spectrometer (LCMS) method for clozapine and its metabolite N-desmethyl clozapine (norclozapine) in human serum","volume":"23","author":"Rao","year":"2009","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.talanta.2016.09.053_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/bmc.997","article-title":"Bioanalytical methods for the determination of antipsychotic drugs","volume":"22","author":"Zhang","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2016.09.053_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jms.1783","article-title":"Identification and quantification of 30 antipsychotics in blood using LC-MS\/MS","volume":"45","author":"Saar","year":"2010","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.talanta.2016.09.053_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.talanta.2016.09.053_bib7","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.npp.1301305","article-title":"Dopamine and serotonin receptor binding and antipsychotic efficacy","volume":"32","author":"Richtand","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.talanta.2016.09.053_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpha.2014.03.003","article-title":"Extraction and determination of trace amounts of chlorpromazine in biological fluids using magnetic solid phase extraction followed by HPLC","volume":"4","author":"Yamini","year":"2014","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.talanta.2016.09.053_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF00315316","article-title":"Pharmacokinetics of chlorpromazine and key metabolites","volume":"45","author":"Yeung","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.talanta.2016.09.053_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.talanta.2016.09.053_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine. Pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.talanta.2016.09.053_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-3565(25)12326-4","article-title":"Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine","volume":"276","author":"Ring","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.talanta.2016.09.053_bib13","doi-asserted-by":"crossref","first-page":"9832","DOI":"10.1073\/pnas.0602398103","article-title":"Mechanism of action of a flavin-containing monooxygenase","volume":"103","author":"Eswaramoorthy","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.talanta.2016.09.053_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/tx00044a001","article-title":"Structural and catalytic properties of the mammalian flavin-containing monooxygenase","volume":"8","author":"Cashman","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.talanta.2016.09.053_bib15","doi-asserted-by":"crossref","unstructured":"S. Bhamre, S.V. Bhagwat, S.V. Shankar, M.R. Boyd, V. Ravindranath, Flavin-Containing Monooxygenase Mediated Metabolism of Psychoactive Drugs by Human Brain Microsomes, 672, 1995, pp. 276\u2013280","DOI":"10.1016\/0006-8993(94)01135-5"},{"key":"10.1016\/j.talanta.2016.09.053_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1389200003339135","article-title":"Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism","volume":"1","author":"Cashman","year":"2000","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.talanta.2016.09.053_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JCP.0b013e318221b408","article-title":"Plasma olanzapine in relation to prescribed dose and other factors","volume":"31","author":"Patel","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.talanta.2016.09.053_bib18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00007691-200208000-00010","article-title":"Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting","volume":"24","author":"Skogh","year":"2002","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2016.09.053_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00007691-200302000-00007","article-title":"Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication","volume":"25","author":"Gex-Fabry","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2016.09.053_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00228-009-0783-8","article-title":"Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure \u2013 an impact similar to male gender or smoking in schizophrenic patients","volume":"66","author":"Ghotbi","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.talanta.2016.09.053_bib21","first-page":"544","article-title":"Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients","volume":"13","author":"S\u00f6derberg","year":"2013","journal-title":"Pharm. J."},{"key":"10.1016\/j.talanta.2016.09.053_bib22","article-title":"Determination of olanzapine and N-desmethyl-olanzapine in plasma using a reversed-phase HPLC coupled with coulochemical detection: correlationcorrelation of olanzapine or N-desmethyl-olanzapine concentration with metabolic parameters","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.talanta.2016.09.053_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchromb.2003.08.036","article-title":"Assaying protein unbound drugs using microdialysis techniques","volume":"797","author":"Tsai","year":"2003","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2016.09.053_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jchromb.2008.09.005","article-title":"Determination of baicalin in rat cerebrospinal fluid and blood using microdialysis coupled with ultra-performance liquid chromatography-tandem mass spectrometry","volume":"874","author":"Huang","year":"2008","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2016.09.053_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2016.01.015","article-title":"An improved microbore UHPLC method with electrochemical detection for the simultaneous determination of low monoamine levels in in vivo brain microdialysis samples","author":"Van Schoors","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.talanta.2016.09.053_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.talanta.2010.11.063","article-title":"A simple and sensitive LC-ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates","volume":"84","author":"Yeniceli","year":"2011","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2016.09.053_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/bmc.3308","article-title":"HPLC-UV method for quantifying etoposide in plasma and tumor interstitial fluid by microdialysis: application to pharmacokinetic studies","volume":"29","author":"Pigatto","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2016.09.053_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fneur.2014.00159","article-title":"Microdialysis monitoring of CSF parameters in severe traumatic brain injury patients: a novel approach","volume":"5","author":"Thelin","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.talanta.2016.09.053_bib29","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1365\/s10337-007-0224-8","article-title":"Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI-LC-MS (ion trap)","volume":"66","author":"Sener","year":"2007","journal-title":"Chromatographia"},{"key":"10.1016\/j.talanta.2016.09.053_bib30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/bmc.3145","article-title":"Determination of cefuroxime lysine in rat brain microdialysates by ultra-fast liquid chromatography with UV and tandem mass spectrometry: application to an acute toxicokinetic study","volume":"28","author":"Zhao","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2016.09.053_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical anti-psychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.talanta.2016.09.053_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2012.00049","article-title":"Typical and atypical antipsychotic drugs increase extracellular histamine levels in the rat medial prefrontal cortex: contribution of histamine H1 receptor blockade","volume":"3","author":"Fell","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.talanta.2016.09.053_bib33","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00213-014-3780-2","article-title":"A systematic microdialysis study of dopamine transmission in the accumbens shell\/core and prefrontal cortex after acute antipsychotics","volume":"232","author":"Tanda","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.talanta.2016.09.053_bib34","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.1073\/pnas.95.19.11462","article-title":"A typical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions","volume":"95","author":"Radke","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.talanta.2016.09.053_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-409X(00)00107-1","article-title":"Methodological issues in microdialysis sampling for pharmacokinetic studies","volume":"45","author":"Lange","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.talanta.2016.09.053_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trac.2014.12.003","article-title":"Microextraction by packed sorbent (MEPS)","volume":"67","author":"Moein","year":"2015","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.talanta.2016.09.053_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00216-008-2305-4","article-title":"Two new techniques for sample preparation in bioanalysis: microextraction in packed sorbent (MEPS) and use of a bonded monolith as sorbent for sample preparation in polypropylene tips for 96-well plates","volume":"393","author":"Blomberg","year":"2009","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2016.09.053_bib38","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1007\/s00216-015-8583-8","article-title":"Determination of illicit drugs and metabolites in oral fluid by microextraction on packed sorbent coupled with LC-MS\/MS","volume":"407","author":"Montesano","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2016.09.053_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chroma.2012.11.056","article-title":"A new approach for antibiotic drugs determination in human plasma by liquid chromatography-mass spectrometry","volume":"1272","author":"Szultka","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.talanta.2016.09.053_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.chroma.2015.07.021","article-title":"An improved analytical strategy combining microextraction by packed sorbent combined with ultra high pressure liquid chromatography for the determination of fluoxetine, clomipramine and their active metabolites in human urine","volume":"1408","author":"Alves","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.talanta.2016.09.053_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.ftd.0000164245.24358.15","article-title":"Assay of olanzapine in human plasma by a rapid and sensitive gas chromatography-nitrogen phosphorus selective detection (GC-NPD) method: validation and comparison with high-performance liquid chromatography-coulometric detection","volume":"27","author":"Ulrich","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2016.09.053_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0378-4347(87)80301-8","article-title":"Gas chromatographic determination of chlorproethazine in plasma","volume":"419","author":"Girre","year":"1987","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.09.053_bib43","first-page":"316","article-title":"HPLC with electrochemical detection to measure chlorpromazine, thioridazine and metabolites in human brain","volume":"90","author":"Svendesen","year":"1986","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.talanta.2016.09.053_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-4347(95)00061-M","article-title":"Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid-chromatography with electrochemical detection","volume":"668","author":"Catlow","year":"1995","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.09.053_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.aca.2004.04.031","article-title":"Rapid analysis of olanzapine and desmethylolanzapine in human plasma using high-performance liquid chromatography with coulometric detection","volume":"516","author":"Sabbioni","year":"2004","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2016.09.053_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.chroma.2006.04.011","article-title":"Determination of olanzapine in rat brain using liquid chromatography with coulometric detection and a rapid solid-phase extraction procedure","volume":"1122","author":"Saracino","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.talanta.2016.09.053_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jchromb.2007.05.015","article-title":"Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection","volume":"856","author":"Zhang","year":"2007","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2016.09.053_bib48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/bmc.275","article-title":"Direct injection HPLC method for the determination of selected phenothiazines in plasma using a Hisep column","volume":"17","author":"Pistos","year":"2003","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2016.09.053_bib49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/(SICI)1099-0801(199911)13:7<445::AID-BMC909>3.0.CO;2-Z","article-title":"Interaction of carbamazepine and chlorpromazine in rabbits","volume":"13","author":"Rukhadze","year":"1999","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2016.09.053_bib50","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jchromb.2005.11.032","article-title":"Automated analysis of quietapine and other antipsychotic drugs in human blood by high-performance-liquid chromatography with column-switching and spectrophotometric detection","volume":"830","author":"Sachse","year":"2006","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2016.09.053_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0378-4347(98)00205-9","article-title":"Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidizability of the compound and the presence of other psychotropic drugs","volume":"714","author":"Olesen","year":"1998","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.09.053_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1570-0232(02)01003-6","article-title":"High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose","volume":"788","author":"Titier","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.09.053_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1570-0232(02)00164-2","article-title":"Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection","volume":"773","author":"Dusci","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.09.053_bib54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.forsciint.2012.01.002","article-title":"Screening and quantification of antipsychotic drugs in human brain tissue by liquid chromatography-tandem mass spectrometry: application to postmortem diagnostics of forensic interest","volume":"219","author":"Sampedro","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.talanta.2016.09.053_bib55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/FTD.0000000000000197","article-title":"Simple and accurate quantitative analysis of 16 antipsychotics and antidepressants in human plasma by ultrafast high-performance liquid chromatography\/tandem mass spectrometry","volume":"37","author":"Wang","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2016.09.053_bib56","doi-asserted-by":"crossref","unstructured":"A. Lemos, I.D. De Souza, J. Eduardo, C. Hallak, D.S. Domingues, A.D.S. Crippa, M. Euge, Determination of drugs in plasma samples by high-performance liquid chromatography \u2013 Tandem Mass Spectrometry for Therapeutic Drug Monitoring of Schizophrenic Patients, 2015, pp. 1\u20138. doi: http:\/\/dx.doi.org\/10.1093\/jat\/bkv107","DOI":"10.1093\/jat\/bkv107"},{"key":"10.1016\/j.talanta.2016.09.053_bib57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.talanta.2015.03.032","article-title":"Hybrid silica monolith for microextraction by packed sorbent to determine drugs from plasma samples by liquid chromatography-tandem mass spectrometry","volume":"140","author":"De Souza","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2016.09.053_bib58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2006.05.031","article-title":"Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach","volume":"843","author":"Kirchherr","year":"2006","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2016.09.053_bib59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jchromb.2012.07.024","article-title":"Quantitative analysis of olanzapine in rat brain microdialysates by HPLC-MS\/MS coupled with column-switching technique","volume":"905","author":"Zheng","year":"2012","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2016.09.053_bib60","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cbf.1145","article-title":"Characterization and modulation by drugs of sheep liver microsomal flavin monooxygenase activity","volume":"23","author":"Can","year":"2005","journal-title":"Cell. Biochem. Funct."},{"key":"10.1016\/j.talanta.2016.09.053_bib61","unstructured":"S.-M. Aatsinki, J. Hokkanen, A. Tolonen, Assessment of Inhibition Potential Towards Non-CYP Mediated Metabolism In Vitro, Admescope Ltd., Oulu, Finland, 2012, p. 1"},{"key":"10.1016\/j.talanta.2016.09.053_bib62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchromb.2004.02.017","article-title":"Microdialysis combined with liquid chromatography-tandem mass spectrometry for the determination of 6-aminobutylphthalide and its main metabolite in the brains of awake freely-moving rats","volume":"805","author":"Qiao","year":"2004","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2016.09.053_bib63","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.peptides.2004.12.019","article-title":"Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson's disease model in rats: brain microdialysis, behavior, and microscopy","volume":"26","author":"Tun\u00e7el","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.talanta.2016.09.053_bib64","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.talanta.2016.09.053_bib65","first-page":"S387","article-title":"HSV-1 induced behavioural changes and microglia cell activation are inhibited by antipsychotics","author":"Doorduin","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.talanta.2016.09.053_bib66","first-page":"227","article-title":"Mapping dopamine receptors in the human brain","volume":"27","author":"Palacios","year":"1988","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.talanta.2016.09.053_bib67","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics, 12th ed.","author":"Brunton","year":"2010"},{"key":"10.1016\/j.talanta.2016.09.053_bib68","unstructured":"ICH Harmonised Tripartite Guideline, Validation of analytical procedure: methodology, in: Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, 1996."},{"key":"10.1016\/j.talanta.2016.09.053_bib69","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation--a revisit with a decade of progress","volume":"12","author":"Shah","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.talanta.2016.09.053_bib70","unstructured":"EMA, Guideline on Bioanalytical Method Validation, 2011.\u00a0\u3008http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf\u3009 (accessed 25.05.16)"},{"key":"10.1016\/j.talanta.2016.09.053_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0021-9673(00)81809-9","article-title":"Use of gradient elution for rapid selection of isocratic conditions in reversed-phase high-performance liquid chromatography","volume":"205","author":"Schoenmakers","year":"1981","journal-title":"J. Chromatogr. A"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003991401630724X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003991401630724X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:06:36Z","timestamp":1749578796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003991401630724X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":71,"alternative-id":["S003991401630724X"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2016.09.053","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A sensitive capillary LC-UV method for the simultaneous analysis of olanzapine, chlorpromazine and their FMO-mediated N-oxidation products in brain microdialysates","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2016.09.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}